Bladder Cancer Detection (Bladder Monitoring) Equipment
-
Manufactured by miR Scientific, LLCbased in USA
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
-
Manufactured by Nucleix Ltd.based in USA
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor ...
-
based in USA
on the same monitor, eliminating the need for surgeons to switch back and forth. This method has the potential to make bladder cancer detection and removal more efficient and accurate, as well as reduce recurrence rates and health care costs. ...
-
based in USA
The conventional method of detecting bladder cancer uses white light during minimally invasive surgery to illuminate the bladder during a procedure called a cystoscopy. White light has been used for decades and is the standard for more than 90% of the market. In typical white light cystoscopy, a small camera is ...
-
Manufactured by Dutch Diagnostics BVbased in NETHERLANDS
The BT test is one of our newer Rapid Tests. Bladder Tumor or Cancer needs to be diagnosed as quickly as possible in order for treatment to be effective. The BT cassette test is an immunochromatographic rapid test for the qualitative detection of bladder cancer antigen (hcfHrp) in human urine. The test is ...
-
Manufactured by Pacific Edge Ltdbased in NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a ...
-
Manufactured by Cysview, Trademark of Photocurebased in USA
Historically, bladder cancer patients are at high risk for disease recurrence and progression,1 which could be due in part to missed tumors and incomplete surgeries because not all cancerous tissue is easy to see under white light. Moving forward, with the availability of Blue Light Cystoscopy with Cysview, that trend may ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you